Related Experiment Videos
Central laboratory sampling plans and quality control in clinical trials
1University of Texas School of Public Health, Houston 77030.
Controlled Clinical Trials
|December 1, 1991
Summary
Quality control in central laboratories for clinical trials can be more efficient. Utilizing over two repeated intrapatient measurements improves precision and reduces patient burden, optimizing quality assessment strategies.
Area of Science:
- Clinical chemistry
- Biostatistics
- Pharmaceutical research
Background:
- Central laboratories are crucial for clinical trial data interpretation.
- Quality control procedures, including precision measurement, are vital but increase patient burden and costs.
- Efficient quality control methods are needed to balance accuracy and resource utilization.
Purpose of the Study:
- To analyze the relationship between the number of participants and repeated measurements on quality control efficiency for central laboratories.
- To determine optimal sampling schemes for efficient quality assessment in clinical trials.
- To provide data on confidence interval lengths for various measurement combinations.
Main Methods:
- Statistical analysis of quality control efficiency based on varying numbers of participants and intrapatient measurements.
- Exploration of different sampling schemes for specimen collection.
- Calculation and presentation of confidence interval lengths for reproducibility variance.
Main Results:
- Quality control efficiency for central laboratories is significantly dependent on the sampling scheme.
- Using more than two repeated intrapatient measurements generally yields a small confidence interval for reproducibility variance.
- The study provides specific confidence interval lengths for different interpatient and intrapatient measurement combinations.
Conclusions:
- Optimizing the number of repeated intrapatient measurements is key to enhancing central laboratory quality control efficiency.
- Efficient sampling strategies can reduce patient burden and clinical trial costs while maintaining data integrity.
- The findings support the use of >2 intrapatient measurements for reliable precision assessment in clinical trials.